2026-04-29T02:37:43Zhttps://repisalud.isciii.es/rest/oai/request

oai:repisalud.isciii.es:20.500.12105/228082024-11-28T20:26:23Zcom_20.500.12105_15322com_20.500.12105_2051col_20.500.12105_16967

00925njm 22002777a 4500 dc Moreno-Garcia, Inmaculada author Meneres-Sancho, Susana author Camacho-Vara de Rey, Carlos author Servera, Mateu author 2019-02 Objective: To examine the efficacy of neurofeedback (NF), behavior therapy (BT), and pharmacology (PH) on the improvement of ADHD-related symptoms. Method: Fifty-nine children with ADHD (M = 8.80 years, SD = 1.92 years) were randomly assigned to one of the three treatments in a pre/post assessment design. Mother- and teacher-rated ADHD scales and children were assessed using The Integrated Visual and Auditory Continuous Performance Test (IVA/CPT). Results: The three treatments were effective on the IVA/CPT, but with different trends. BT and especially NF achieved improvement on response control and attention, and PH mainly in visual attention. On the rating scales, BT improved all measures, and NF and PH had a minor but interesting influence. Conclusion: From a global perspective, behavior therapy had the most extensive results, but PH had the greatest capacity to improve overall attention. NF was able to improve both control response and inattention. Clinical implications are discussed. Moreno-Garcia Inmaculada, Meneres-Sancho Susana, Camacho-Vara De Rey Carlos, Servera Mateu. A Randomized Controlled Trial to Examine the Posttreatment Efficacy of Neurofeedback, Behavior Therapy, and Pharmacology on ADHD Measures. J Atten Disord. 2019 Feb;23(4):374-383. Epub 2017 Feb 1. 1087-0547 http://hdl.handle.net/20.500.13003/8891 https://hdl.handle.net/20.500.12105/22808 29254414 10.1177/1087054717693371 1557-1246 Journal of Attention Disorders 2-s2.0-85041542074 456737600007 L626490416 Randomized controlled trial Neurofeedback Pharmacological treatment Behavior therapy ADHD A Randomized Controlled Trial to Examine the Posttreatment Efficacy of Neurofeedback, Behavior Therapy, and Pharmacology on ADHD Measures